ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.411,55
-0,27%
S&P 500
5.321,41
0,25%
US Dollar vs BRL
5,1229
-0,01%
Bitcoin
70.132,39
0,00%
Brent Oil
82,21
-0,29%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. NanoVibronix Inc (NAOV)

  7. NanoVibronix Inc (NAOV) Notícias

NAOV

NanoVibronix (NAOV)

NanoVibronix Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:NAOV
DataHoraFonteTítuloCódigoCompanhia
16/05/202417:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAOVNanoVibronix Inc
16/05/202409:30Business WireNanoVibronix Issues Letter to StockholdersNASDAQ:NAOVNanoVibronix Inc
15/05/202414:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NAOVNanoVibronix Inc
14/05/202409:30Business WireNanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShieldNASDAQ:NAOVNanoVibronix Inc
01/05/202409:00Business WireNanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract AwardNASDAQ:NAOVNanoVibronix Inc
28/03/202409:30Business WireNanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShieldNASDAQ:NAOVNanoVibronix Inc
26/02/202419:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAOVNanoVibronix Inc
14/02/202417:45Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:NAOVNanoVibronix Inc
17/01/202418:31Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NAOVNanoVibronix Inc
06/12/202311:00Business WireNanoVibronix Featured in Your Bladder Health MagazineNASDAQ:NAOVNanoVibronix Inc
04/12/202311:00Business WireNanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution OpportunityNASDAQ:NAOVNanoVibronix Inc
28/11/202311:00Business WireNanoVibronix Announces Agreement for Clinical Study of UroShield at the University of MichiganNASDAQ:NAOVNanoVibronix Inc
21/11/202310:30Business WireNanoVibronix Regains Nasdaq ComplianceNASDAQ:NAOVNanoVibronix Inc
14/11/202310:30Business WireNanoVibronix Issues Letter to ShareholdersNASDAQ:NAOVNanoVibronix Inc
07/11/202310:30Business WireNanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1NASDAQ:NAOVNanoVibronix Inc
27/09/202309:00Business WireNanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug TariffNASDAQ:NAOVNanoVibronix Inc
22/09/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NAOVNanoVibronix Inc
21/09/202311:27Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:NAOVNanoVibronix Inc
21/09/202311:25Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:NAOVNanoVibronix Inc
13/09/202317:45Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:NAOVNanoVibronix Inc
12/09/202317:15Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:NAOVNanoVibronix Inc
06/09/202309:30Business WireNanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual MeetingNASDAQ:NAOVNanoVibronix Inc
30/08/202315:29Business WireNanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:NAOVNanoVibronix Inc
30/08/202309:30Business WireNanoVibronix Cites Positive Results from Independent Testing of UroShieldNASDAQ:NAOVNanoVibronix Inc
29/08/202317:05Business WireNanoVibronix Responds to CMS’ Determination for PainShieldNASDAQ:NAOVNanoVibronix Inc
28/08/202309:30Business WireNanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services’ Drug TariffNASDAQ:NAOVNanoVibronix Inc
23/08/202309:45Business WireNanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield PlusNASDAQ:NAOVNanoVibronix Inc
07/08/202318:14Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NAOVNanoVibronix Inc
17/07/202318:01Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:NAOVNanoVibronix Inc
21/06/202318:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NAOVNanoVibronix Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:NAOV

Seu Histórico Recente

COIN
FRCOEUR
KOSPI
500008
Shinhan Investment
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados